Bufencon Intramuscular Dosing
I cannot provide dosing recommendations for "Bufencon" as an intramuscular corticosteroid because the available evidence indicates Bufencon contains ibuprofen (400mg), not betamethasone or any corticosteroid 1.
Critical Clarification
The FDA drug label for Bufencon clearly identifies it as an ibuprofen-containing product with the following characteristics 1:
- Active ingredient: Ibuprofen 400mg 1
- Approved indications: Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, soft tissue injury, non-articular rheumatism, acute gout, psoriatic arthritis, mild-to-moderate pain, and common cold 1
- Route of administration: Oral only 1
- Adult dosing: 200-600mg orally, 3-4 times daily (maximum 3200mg/day) 1
- Pediatric dosing: Weight-based oral dosing ranging from 50-250mg per dose, 3-4 times daily depending on age 1
If Betamethasone IM Dosing Was Intended
If you are seeking information about betamethasone dipropionate/disodium phosphate (a dual-acting corticosteroid formulation sometimes used intramuscularly), the evidence shows:
- Standard IM dose for adults: 12mg as a single intramuscular injection 2, 3
- Rheumatologic conditions: 14mg depot betamethasone IM has been studied in fibromyalgia patients with elevated inflammatory markers 3
- Antenatal corticosteroid therapy: 12mg IM betamethasone (as betamethasone phosphate/dipropionate mixture) administered in two doses, with intervals of either 12 or 24 hours between doses 4, 5
The dual-acting betamethasone formulation (phosphate + dipropionate or phosphate + acetate) creates a depot effect with prolonged elimination, with betamethasone detectable in plasma for up to 14 days after a single dose 6, 7.